Article Text

This article has a correction. Please see:

Download PDFPDF
High frequency of the ApoB-100 R3500Q mutation in Bulgarian hypercholesterolaemic subjects
  1. Anelia Horvatha,
  2. Alexey Savovb,
  3. Stephen Kirova,
  4. Elina Karshelovac,
  5. Iva Paskalevad,
  6. Assen Goudevc,
  7. Varban Ganeva,e
  1. aDepartment of Chemistry and Biochemistry, Medical University of Sofia, 2 Zdrave Str, 1431 Sofia, Bulgaria, bUniversity Hospital for Obstetrics and Gynaecology, Medical University of Sofia, Sofia, Bulgaria, cDepartment of Propaedeutics of Internal Diseases, Medical University of Sofia, Sofia, Bulgaria, dNational Centre of Cardiovascular Diseases, Sofia, Bulgaria, eInstitute of International Health, Michigan State University, East Lansing, MI, USA
  1. Dr Ganev, ganev{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Editor—One of the most common single site mutations in the human ApoB gene, R3500Q, results in mild to severe hypercholesterolaemia and an increased risk for early onset atherosclerosis.1 Intensive mutation screening studies of the ApoB gene in subjects with hypercholesterolaemia have identified a few less frequent variants, associated with an even milder phenotype and localised within a region coding for the ApoB-100 receptor binding domain.2 3

It is widely accepted that the average population frequency of the R3500Q mutation is about 1:500-1:700 among white populations.4 However, results from population studies, as well as data from studies of high risk groups in Europe, show that frequencies vary to a large extent among population groups, ranging between 1:715 and 1:1250.6 The simultaneous occurrence of the underlying G to A substitution and a rareApoB haplotype across different ethnic groups favours the hypothesis of a common origin of the R3500Q mutation and its further migration spread.7 Population groups with the highest frequencies are clustered in central Europe, and the mutation frequency decreases as one moves east, north, and south west,5 6 8-22 becoming extremely rare in Finland, southern Italy, and Spain.23-25 There is a lack of information about the mutation prevalence in the south east of central Europe, with the exception of one study on hypercholesterolaemic subjects from the fringes of Europe (Turkey) that failed to detect the R3500Q mutation.26 This lack of information about a sizeable region of Europe flanked by populations with high (Austria18 and Hungary19) and extremely low prevalence (Turkey26) leaves open the question of a frequency gradient to the south east.

This study of the occurrence of the R3500Q mutation and its associated haplotype(s) in subjects with hypercholesterolaemia from Bulgaria aimed to obtain data from a …

View Full Text

Linked Articles

  • Correction
    BMJ Publishing Group Ltd